Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Neuroblastoma Precision Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
- Status
- COMPLETED
- Phase
- NA
High-Risk Neuroblastoma Chemotherapy Without G-CSF
- Status
- COMPLETED
- Phase
- NA
Next Generation Personalized Neuroblastoma Therapy
- Status
- TERMINATED
- Phase
- PHASE1
Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients
- Status
- TERMINATED
- Phase
- N/A
Neuroblastoma Maintenance Therapy Trial
- Status
- RECRUITING
- Phase
- PHASE2
Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
NB2013-HR German (GPOH) / Dutch (DCOG) Trial
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Tolcapone With Oxaliplatin for Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Status
- RECRUITING
- Phase
- PHASE2